Glutathione S-transferases in wild-type and doxorubicin-resistant MCF-7 human breast cancer cell lines

Xenobiotica

Volumn 29, Issue 2, 1999, Pages 155-170

  Wang, K ^a   Ramji, S ^a   Bhathena, A ^a   Lee, C ^a   Riddick, D S ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; ETACRYNIC ACID; GLUTATHIONE; GLUTATHIONE TRANSFERASE; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN;

ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG RESISTANCE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0032941798     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982599238713     Document Type: Article

References (83)

1. AKMAN, S. A., FORREST, G., CHU, F.-F., ESWORTHY, R. S. and DOROSHOW, J. H., 1990, Antioxidant and xenobiotic-metabolizing enzyme gene expression in doxorubicin-resistant MCF-7 breast cancer cells. Cancer Research, 50, 1397-1402.
2. ALBIN, N., MASSAAD, L., TOUSSAINT, C., MATHIEU, M. C., MORIZET, J., PARISE, O., GOUYETTE, A. and CHABOT, G. G., 1993, Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissues. Cancer Research, 53, 3541-3546.
3. ALIN, P., DANIELSON, U. H. and MANNERVIK, B., 1985, 4-Hydroxyalk-2-enals are substrates for glutathione S-transferases. FEBS Letters, 179, 267-270.
4. ALLEY, M. C., SCUDIERO, D. A., MONKS, A., HURSEY, M. L., CZERWINSKI, M. J., FINE, D. L., ABBOTT, B. J., MAYO, J. G., SHOEMAKER, R. H. and BOYD, M. R., 1988, Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Research, 48, 589-601.
5. r 190,000 multidrug resistance protein (MRP) in drug-selected and transfected human tumor cells. Cancer Research, 55, 102-110.
6. BAN, N., TAKAHASHI, Y., TAKAYAMA, T., KURA, T., KATAHIRA, T., SAKAMAKI, S. and NIITSU, Y., 1996, Transfection of glutathione S-transferase (GST)-π antisense complementary DNA increases the sensitivity of a colon cancer cell line to adriamycm, cisplatin, melphalan, and etoposide. Cancer Research, 56, 3577-3582.
7. BARNOUIN, K., LEIER, I., JEDLITSCHKY, G., POURTIER-MANZANEDO, A., KONIG, J., LEHMANN, W.-D. and KEPPLER, D., 1998, Multidrug resistance protein-mediated transport of chlorambucil and melphalan conjugated to glutathione. British Journal of Cancer, 77, 201-209.
8. BATIST, G., TULPULE, A., SINHA, B. K., KATKI, A. G., MYERS, C. E. and COWAN, K. H., 1986, Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. Journal of Biological Chemistry, 261, 15544-15549.
9. BELLAMY, W. T., 1996, P-glycoproteins and multidrug resistance. Annual Review of Pharmacology and Toxicology, 36, 161-183.
10. BLACK, S. M., BEGGS, J. D., HAYES, J. D., BARTOSZEK, A., MURAMATSU, M., SAKAI, M. and WOLF, C. R., 1990, Expression of human glutathione S-transferases in Saccharomyces cerevisiae confers resistance to the anticancer drugs adriamycin and chlorambucil. Biochemical Journal, 268, 309-315.
11. BRADFORD, M. M., 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 72, 248-254.
12. BUDWORTH, J., GANT, T. W. and GESCHER, A., 1997, Coordinate loss of protein kinase C and multidrug resistance gene expression in revenant MCF-7/Adr breast carcinoma cells. British Journal of Cancer, 75, 1330-1335.
13. CHANEY, S. G. and SANCAR, A., 1996, DNA repair: enzymatic mechanisms and relevance to drug response. Journal of the National Cancer Institute, 88, 1346-1360.
14. CHEN, A. Y. and LIU, L. F., 1994, DNA topoisomerases: essential enzymes and lethal targets. Annual Review of Pharmacology and Toxicology, 34, 191-218.
15. CHEN, G. and WAXMAN, D. J., 1995, Complete reversal by thaliblastine of 490-fold adriamycin resistance in multidrug-resistant (MDR) human breast cancer cells: evidence that multiple biochemical changes in MDR cells need not correspond to multiple functional determinants for drug resistance. Journal of Pharmacology and Experimental Therapeutics, 274, 1271-1277.
16. CHOMCZYNSKI, P. and SACCHI, N., 1987, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry, 162, 156-159.
17. CHU, F.-F., ESWORTHY, R. S., DOROSHOW, J. H., DOAN, K. and LIU, X.-F., 1992, Expression of plasma glutathione peroxidase in human liver in addition to kidney, heart, lung and breast in humans and rodents. Blood, 79, 3233-3238.
18. CIACCIO, P. J., SHEN, H. X., JAISWAL, A. K., LYTTLE, M. H. and TEW, K. D., 1995, Modulation of detoxification gene expression in human colon HT29 cells by glutathione S-transferase inhibitors. Molecular Pharmacology, 48, 639-647.
19. COMSTOCK, K. E., WIDERSTEN, M., HAO, X. Y., HENNER, W. D. and MANNERVIK, B., 1994, A comparison of the enzymatic and physicochemical properties of human glutathione transferase M4-4 and three other human Mu class enzymes. Archives of Biochemistry and Biophysics, 311, 487-495.
20. COWAN, K. H., BATIST, G., TULPULE, A., SINHA, B. K. and MYERS, C. E., 1986, Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats. Proceedings of the National Academy of Sciences, USA, 83, 9328-9332.
21. DE LA TORRE, M., HAO, X. Y., LARSSON, R., NYGREN, P., TSURUO, T., MANNERVIK, B. and BERGH, J., 1993, Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases. Anticancer Research, 13, 1425-1430.
22. DOROSHOW, J. H., AKMAN, S., CHU, F.-F. and ESWORTHY, S., 1990, Role of the glutathione-glutathione peroxidase cycle in the cytotoxicity of the anticancer quinones. Pharmacology and Therapeutics, 47, 359-370.
23. DOROSHOW, J. H., AKMAN, S., ESWORTHY, S., CHU, F.-F. and BURKE, T., 1991, Doxorubicin resistance conferred by selective enhancement of intracellular glutathione peroxidase or superoxide dismutase content in human MCF-7 breast cancer cells. Free Radical Research Communications, 12-13, 779-781.
24. DUSRE, L., MIMNAUGH, E. G., MYERS, C. E. and SINHA, B. K., 1989, Potentiation of doxorubicin cytotoxicity by buthionine sulfoximine in multidrug-resistant human breast tumor cells. Cancer Research, 49, 511-515.
25. ESWORTHY, R. S., BAKER, M. A. and CHU, F.-F., 1995, Expression of selenium-dependent glutathione peroxidase in human breast tumor cell lines. Cancer Research, 55, 957-962.
26. FAIRCHILD, C. R., IVY, S. P., KAO-SHAN, C.-S., WHANG-PENG, J., ROSEN, N., ISRAEL, M. A., MELERA, P. W., COWAN, K. H. and GOLDSMITH, M. E., 1987, Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells. Cancer Research, 47, 5141-5148.
27. FAIRCHILD, C. R., MOSCOW, J. A., O'BRIEN, E. E. and COWAN, K. H., 1990, Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-π. Molecular Pharmacology, 37, 801-809.
28. FLATGAARD, J. E., BAUER, K. E. and KAUVAR, L. M., 1993, Isozyme specificity of novel glutathione-S-transferase inhibitors. Cancer Chemotherapy and Pharmacology, 33, 63-70.
29. FLENS, M. J., IZQUIERDO, M. A., SCHEEFER, G. L., FRITZ, J. M., MEIJER, C. J. L. M., SCHEPER, R. J. and ZAMAN, G. J. R., 1994, Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. Cancer Research, 54, 4557-4563.
30. FORRESTER, L. M., HAYES, J. D., MILLIS, R., BARNES, D., HARRIS, A. L., SCHLAGER, J. J., POWIS, G. and WOLF, C. R., 1990, Expression of glutathione S-transferases and cytochromes P450 in normal and tumor breast tissue. Carcinogenesis, 11, 2163-2170.
31. GIACCONE, G., LINN, S. C. and PINEDO, H. M., 1995, Multidrug resistance in breast cancer: mechanisms, strategies. European Journal of Cancer, 31A, S15-17.
32. GRANT, C. E., VALDIMARSSON, G., HIPFNER, D. R., ALMQUIST, K. C., COLE, S. P. C. and DEELEY, R. G., 1994, Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Research, 54, 357-361.
33. HABIG, W. H., PABST, M. J. and JAKOBY, W. B., 1974, Glutathione S-transferases: the first enzymatic step in mercapturic acid formation. Journal of Biological Chemistry, 249, 7130-7139.
34. HARPER, P. A., PROKIPCAK, R. D., BUSH, L. E., GOLAS, C. L. and OKEY, A. B., 1991, Detection and characterization of the Ah-receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in the human colon adenocarcinoma cell line LS180. Archives of Biochemistry and Biophysics, 290, 27-36.
35. HARRIS, A. L. and CARMICHAEL, J., 1995, Topoisomerase inhibitors and multiple drug resistance mechanisms in human breast cancer. In R. B. Dickson and M. E. Lippman (eds), Drug and Hormonal Resistance in Breast Cancer: Cellular and Molecular Mechanisms (New York: Ellis Horwood), pp. 303-322.
36. HAYES, J. D. and PULFORD, D. J., 1995, The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Critical Reviews in Biochemistry and Molecular Biology, 30, 445-600.
37. HE, N. G., SINGHAL, S. S., SRIVASTAVA, S. K., ZIMNIAK, P., AWASTHI, Y. C. and AWASTHI, S., 1996, Transfection of a 4-hydroxynonenal metabolizing glutathione S-transferase isozyme, mouse GSTA4-4, confers doxorubicin resistance to Chinese hamster ovary cells. Archives of Biochemistry and Biophysics, 333, 214-220.
38. HIBATSCH, I., RIDDERSTROM, M. and MANNERVIK, B., 1998, Human glutathione transferase A4-4: an α class enzyme with high catalytic efficiency in the conjugation of 4-hydroxy nonenal and other genotoxic products of lipid peroxidation. Biochemical Journal, 330, 175-179.
39. JEDLITSCHKY, G., LEIER, I., BUCHHOLZ, U., BARNOUIN, K., KURZ, G. and KEPPLER, D., 1996, Transport of glutathione, glucuronate and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Research, 56, 988-994.
40. KELLEY, M. K., ENGQVIST-GOLDSTEIN, A., MONTALI, J. A., WHEATLEY, J. B., SCHMIDT, D. E. and KAUVAR, L. M., 1994, Variability of glutathione S-transferase isoenzyme patterns in matched normal and cancer human breast tissue. Biochemical Journal, 304, 843-848.
41. LACAVE, R., COULET, F., RICCI, S., TOUBOUL, E., FLAHAULT, A., RATEAU, J. G., CESARI, D, LEFRANC, J. P. and BERNAUDIN, J. F., 1998, Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP and GSTp gene expression in breast carcinomas. British Journal of Cancer, 77, 694-702.
42. LAEMMLI, U. K., 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
43. LANDIS, S. H., MURRAY, T., BOLDEN, S. and WINGO, P. A., 1998, Cancer statistics, 1998. CA-A Cancer Journal for Clinicians, 48, 6-29.
44. LAUTIER, D., CANITROT, Y., DEELEY, R. G. and COLE, S. P. C., 1996, Multidrug resistance mediated by the multidrug resistance protein (MRP) gene. Biochemical Pharmacology, 52, 967-977.
45. LAWRENCE, R. A. and BURK, R. F., 1976, Glutathione peroxidase activity in selenium-deficient rat liver. Biochemical and Biophysical Research Communications, 71, 952-958.
46. 4, and structurally related conjugates. Journal of Biological Chemistry, 269, 27807-27810.
47. LEVENSON, A. S. and JORDAN, V. C., 1997, MCF-7: the first hormone-responsive breast cancer cell line. Cancer Research, 57, 3071-3078.
48. LEYLAND-JONES, B. R., TOWNSEND, A. J., TU, C.-P. D., COWAN, K. H. and GOLDSMITH, M. E., 1991, Antineoplastic drug sensitivity of human MCF-7 breast cancer cells stably transfected with a human α class glutathione S-transferase gene. Cancer Research, 51, 587-594.
49. 4 and chemotherapeutic agents in membrane vesicles: demonstration of glutathione-dependent vincristine transport. Journal of Biological Chemistry, 271, 9675-9682.
50. LYTTLE, M. H., HOCKER, M. D., HUI, H. C., CALDWELL, C. G., AARON, D. T., ENGQVIST-GOLDSTEIN, A., FLATGAARD, J. E. and BAUER, K. E., 1994, Isozyme-specific glutathione-S-transferase inhibitors: design and synthesis. Journal of Medicinal Chemistry, 37, 189-194.
51. MANNERVIK, B., ALIN, P., GUTHENBERG, C., JENSSON, H., TAHIR, M. K., WARHOLM, M. and JORNVALL, H, 1985, Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties. Proceedings of the National Academy of Sciences, USA, 82, 7202-7206.
52. MANNERVIK, B. and WIDERSTEN, M., 1995, Human glutathione transferases: classification, tissue distribution, structure, and functional properties. In G. M. Pacifici and G. N. Fracchia (eds), Advances in Drug Metabolism in Man (Brussels: European Commission), pp. 407-459.
53. MIMNAUGH, E. G., DUSRE, L., ATWELL, J. and MYERS, C. E., 1989, Differential oxygen radical susceptibility of adriamycin-sensitive and -resistant MCF-7 human breast tumor cells. Cancer Research, 49, 8-15.
54. MOORE, M., WANG, X. H., LU, Y. F., WORMKE, M., CRAIG, A., GERLACH, J. H., BURGHARDT, R., BARHOUMI, R. and SAFE, S., 1994, Benzo[a]pyrene-resistant MCF-7 human breast cancer cells: a unique aryl hydrocarbon-nonresponsive clone. Journal of Biological Chemistry, 269, 11751-11759.
55. MORGAN, A. S., CIACCIO, P. J., TEW, K. D. and KAUVAR, L. N., 1996, Isozyme specific glutathione S-transferase inhibitors potentiate drug sensitivity in cultured human tumor cell lines. Cancer Chemotherapy and Pharmacology, 37, 363-370.
56. MORROW, C. S. and COWAN, K. H., 1993, Antineoplastic drug resistance and breast cancer. Annals of the New York Academy of Sciences, 698, 289-312.
57. MORROW, C. S., DIAH, S., SMITHERMAN, P. K., SCHNEIDER, E. and TOWNSEND, A. J., 1998, Multidrug resistance protein and glutathione S-transferase P1 1 act in synergy to confer protection from 4-nitroquinoline 1-oxide toxicity. Carcinogenesis, 19, 109-115.
58. MOSCOW, J. A., TOWNSEND, A. J. and COWAN, K. H., 1989, Elevation of π class glutathione S-transferase activity in human breast cancer cells by transfection of the GSTπ gene and its effect on sensitivity to toxins. Molecular Pharmacology, 36, 22-28.
59. MULDERS, T. M. T., KEIZER, H. J., BREIMER, D. D. and MULDER, G. J., 1995, In vivo characterization and modulation of the glutathione/glutathione S-transferase system in cancer patients. Drug Metabolism Reviews, 27, 191-229.
60. MULLER, M., MEIJER, C., ZAMAN, G. J. R., BORST, P., SCHEPER, R. J., MULDER, N. H., DEVRIES, E. G. E. and JANSEN, P. L. M., 1994, Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proceedings of the National Academy of Sciences, USA, 91, 13033-13037.
61. NAGOURNEY, R. A., MESSENGER, J. C., KERN, D. H. and WEISENTHAL, L. M., 1990, Enhancement of anthracycline and alkylator cytotoxicity by ethacrynic acid in primary cultures of human tissues. Cancer Chemotherapy and Pharmacology, 26, 318-322.
62. NAKAGAWA, K., SAIJO, N., TSUCHIDA, S., SAKAI, M., TSUNOKAWA, Y., YOKOTA, J., MURAMATSU, M., SATO, K., TERADA, M. and TEW, K. D., 1990, Glutathione-S-transferase π as a determinant of drug resistance in transfectant cell lines. Journal of Biological Chemistry, 265, 4296-4301.
63. NAKANISHI, Y., MATSUKI, H., TAKAYAMA, K., YATSUNAMI, J., KAWASAKI, M., ABE, M. and HARA, N., 1997, Glutathione derivatives enhance adriamycin cytotoxicity in a human lung adenocarcinoma cell line. Anticancer Research, 17, 2129-2134.
64. NOOTER, K., DE LA RIVIERE, G. B., LOOK, M. P., VAN WINGERDEN, K. E., HENZEN-LOGMANS, S. C., SCHEPER, R. J., FLENS, M. J., KLIJN, J. G. M., STOTER, G. and FOEKENS, J. A., 1997, The prognostic significance of expression of the multidrug resistance associated protein (MRP) in primary breast cancer. British Journal of Cancer, 76, 486-493.
65. O'DWYER, P. J., LACRETA, F. P., NASH, S., TINSLEY, P. W., SCHILDER, R., CLAPPER, M. L., TEW, K. D., PANTING, L., LITWIN, S., COMIS, R. L. and OZOLS, R. F., 1991, Phase I study of thiotepa in combination with the glutathione S-transferase inhibitor ethacrynic acid. Cancer Research, 51, 6059-6065.
66. OUWERKERK-MAHADEVAN, S., VANBOOM, J. H., DREEF-TROMP, M. C., PLOEMEN, J. H. T. M., MEYER, D. J. and MULDER, G. J., 1995, Glutathione analogues as novel inhibitors of rat and human glutathione S-transferase isoenzymes, as well as of glutathione conjugation in isolated rat hepatocytes and in the rat in vivo. Biochemical Journal, 308, 283-290.
67. RAPPA, G., LORICO, A., FLAVELL, R. A. and SARTORELLI, A. C., 1997, Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins. Cancer Research, 57, 5232-5237.
68. RAVDIN, P. M., 1995, Anthracycline resistance in breast cancer: clinical applications of current knowledge. European Journal of Cancer, 31A, S11-14.
69. SAMBROOK, J., FRITSCH, E. F. and MANIATIS, T., 1989, Molecular Cloning: a Laboratory Manual, 2nd edn (Cold Spring Harbor: Cold Spring Harbor Laboratory).
70. SCHNEIDER, E., HORTON, J. K., YANG, C.-H., NAKAGAWA, M. and COWAN, K. H., 1994, Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance. Cancer Research, 54, 152-158.
71. SINGHAL, S. S., SAXENA, M., AHMAD, H., AWASTHI, S., HAQUE, A. K. and AWASTHI, Y. C., 1992, Glutathione S-transferases of human lung: characterization and evaluation of the protective role of the α-class isozymes against lipid peroxidation. Archives of Biochemistry and Biophysics, 299, 232-241.
72. SINHA, B. K., KATKI, A. G., BATIST, G., COWAN, K. H. and MYERS, C. E., 1987, Differential formation of hydroxyl radicals by adriamycin in sensitive and resistant MCF-7 human breast tumor cells: implications for the mechanism of action. Biochemistry, 26, 3776-3781.
73. SINHA, B. K., MIMNAUGH, E. G., RAJAGOPALAN, S. and MYERS, C. E., 1989, Adriamycin activation and oxygen free radical formation in human breast tumor cells: protective role of glutathione peroxidase in adriamycin resistance. Cancer Research, 49, 3844-3848.
74. TEW, K. D., 1994, Glutathione-associated enzymes in anticancer drug resistance. Cancer Research, 54, 4313-4320.
75. TEW, K. D., BOMBER, A. M. and HOFFMAN, S. J., 1988, Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines. Cancer Research, 48, 3622-3625.
76. TEW, K. D., HOUGHTON, P. J. and HOUGHTON, J. A., 1993, Preclinical and Clinical Modulation of Anticancer Drugs (Boca Raton: CRC Press).
77. TEW, K. D., MONKS, A., BARONE, L., ROSSER, D., AKERMAN, G., MONTALI, J. A., WHEATLEY, J. B. and SCHMIDT, D. E., Jr, 1996, Glutathione-associated enzymes in the human cell lines of the National Cancer Institute drug screening program. Molecular Pharmacology, 50, 149-159.
78. TOWBIN, H., STAEHELIN, T. and GORDON, J., 1979, Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences, USA, 76, 4350-4354.
79. TOWNSEND, A. J., TU, C.-P., D. and COWAN, K. H., 1992, Expression of human ft or a class glutathione S-transferases in stably transfected human MCF-7 breast cancer cells: effect on cellular sensitivity to cytotoxic agents. Molecular Pharmacology, 41, 230-236.
80. WAXMAN, D. J., 1991, Rat hepatic P450IIA and P450IIC subfamily expression using catalytic, immunochemical, and molecular probes. Methods in Enzymology, 206, 249-267.
81. WAXMAN, D. J., SUNDSETH, S. S., SRIVASTAVA, P. K. and LAPENSON, D. P., 1992, Gene-specific oligonucleotide probes for α, μ, π, and microsomal rat glutathione S-transferases: analysis of liver transferase expression and its modulation by hepatic enzyme inducers and platinum anticancer drugs. Cancer Research, 52, 5797-5802.
82. WHELAN, R. D., HOSKING, L. K., TOWNSEND, A. J., COWAN, K. H. and HILL, B. T., 1989, Differential increases in glutathione S-transferase activities in a range of multidrug-resistant human tumor cell lines. Cancer Communications, 1, 359-365.
83. ZAMAN, G. J. R., LANKELMA, J., VAN TELLINGEN, O., BEIJNEN, J., DEKKER, H., PAULUSMA, C., OUDE ELFERINK, R. P. J., BAAS, F. and BORST, P., 1995, Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proceedings of the National Academy of Sciences, USA, 92, 7690-7694.